Supernus Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Supernus Pharmaceuticals last closed at $42.67 (+1.26%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -22.3×. Its overall grade ranks 290 of 738 stocks in Healthcare.
About this company
Supernus Pharmaceuticals last closed at $42.67 (+1.26%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 290/738
Valuation grade A+
Related stocks
- AbbVieCompetitor
중추신경계(CNS) 치료제 영역에서 경쟁하는 대형 제약사
- Jazz PharmaceuticalsCompetitor
신경·정신질환 및 희귀질환 치료제 분야에서 경쟁하는 제약사
- Teva PharmaceuticalCompetitor
중추신경계 및 제네릭/브랜드 의약품에서 경쟁하는 글로벌 제약사
About Supernus Pharmaceuticals
- What technical signals does Supernus Pharmaceuticals (SUPN) have?
- Supernus Pharmaceuticals current technical signals: no active technical signal.
- Is Supernus Pharmaceuticals a cup-and-handle pattern?
- No. Supernus Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Supernus Pharmaceuticals?
- Market cap: $2.45B. Trailing 12 months PER: -22.3×. Latest quarter PBR: 2.37×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Supernus Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.